Global Cancer Immunotherapies Sales Market Report 2024
The global Cancer Immunotherapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Immunotherapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Monoclonal Antibodies (MABs)
Cancer Vaccines
Immunomodulators
Adoptive Cell transfer
Checkpoint Inhibitors
Segment by Application
Breast Cancer
Leukemia
Lymphoma
Melanoma
Colorectal Cancer
Non-Small Cell Lung Cancer
The Cancer Immunotherapies market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Cancer Immunotherapies market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Amgen
AstraZeneca
Roche
Bristol-Myers Squibb
Bayer
Merck
ARMO BioSciences (Eli Lilly)
Novartis
Pfizer
Johnson & Johnson
AbbVie
Gilead Sciences
Table of Content
1 Cancer Immunotherapies Market Overview
1.1 Cancer Immunotherapies Product Scope
1.2 Cancer Immunotherapies Segment by Type
1.2.1 Global Cancer Immunotherapies Sales by Type (2016 & 2021 & 2027)
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Cancer Vaccines
1.2.4 Immunomodulators
1.2.5 Adoptive Cell transfer
1.2.6 Checkpoint Inhibitors
1.3 Cancer Immunotherapies Segment by Application
1.3.1 Global Cancer Immunotherapies Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Breast Cancer
1.3.3 Leukemia
1.3.4 Lymphoma
1.3.5 Melanoma
1.3.6 Colorectal Cancer
1.3.7 Non-Small Cell Lung Cancer
1.4 Cancer Immunotherapies Market Estimates and Forecasts (2016-2027)
1.4.1 Global Cancer Immunotherapies Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Cancer Immunotherapies Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Cancer Immunotherapies Price Trends (2016-2027)
2 Cancer Immunotherapies Estimates and Forecasts by Region
2.1 Global Cancer Immunotherapies Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Cancer Immunotherapies Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Cancer Immunotherapies Sales Market Share by Region (2016-2021)
2.2.2 Global Cancer Immunotherapies Revenue Market Share by Region (2016-2021)
2.3 Global Cancer Immunotherapies Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Cancer Immunotherapies Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Cancer Immunotherapies Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Cancer Immunotherapies Estimates and Projections (2016-2027)
2.4.2 Europe Cancer Immunotherapies Estimates and Projections (2016-2027)
2.4.3 China Cancer Immunotherapies Estimates and Projections (2016-2027)
2.4.4 Japan Cancer Immunotherapies Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Cancer Immunotherapies Estimates and Projections (2016-2027)
2.4.6 India Cancer Immunotherapies Estimates and Projections (2016-2027)
3 Global Cancer Immunotherapies Competition Landscape by Players
3.1 Global Top Cancer Immunotherapies Players by Sales (2016-2021)
3.2 Global Top Cancer Immunotherapies Players by Revenue (2016-2021)
3.3 Global Cancer Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Immunotherapies as of 2020)
3.4 Global Cancer Immunotherapies Average Price by Company (2016-2021)
3.5 Manufacturers Cancer Immunotherapies Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Cancer Immunotherapies Market Size by Type
4.1 Global Cancer Immunotherapies Historic Market Review by Type (2016-2021)
4.1.1 Global Cancer Immunotherapies Sales Market Share by Type (2016-2021)
4.1.2 Global Cancer Immunotherapies Revenue Market Share by Type (2016-2021)
4.1.3 Global Cancer Immunotherapies Price by Type (2016-2021)
4.2 Global Cancer Immunotherapies Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Cancer Immunotherapies Sales Forecast by Type (2022-2027)
4.2.2 Global Cancer Immunotherapies Revenue Forecast by Type (2022-2027)
4.2.3 Global Cancer Immunotherapies Price Forecast by Type (2022-2027)
5 Global Cancer Immunotherapies Market Size by Application
5.1 Global Cancer Immunotherapies Historic Market Review by Application (2016-2021)
5.1.1 Global Cancer Immunotherapies Sales Market Share by Application (2016-2021)
5.1.2 Global Cancer Immunotherapies Revenue Market Share by Application (2016-2021)
5.1.3 Global Cancer Immunotherapies Price by Application (2016-2021)
5.2 Global Cancer Immunotherapies Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Cancer Immunotherapies Sales Forecast by Application (2022-2027)
5.2.2 Global Cancer Immunotherapies Revenue Forecast by Application (2022-2027)
5.2.3 Global Cancer Immunotherapies Price Forecast by Application (2022-2027)
6 North America Cancer Immunotherapies Market Facts & Figures
6.1 North America Cancer Immunotherapies Sales by Company
6.1.1 North America Cancer Immunotherapies Sales by Company (2016-2021)
6.1.2 North America Cancer Immunotherapies Revenue by Company (2016-2021)
6.2 North America Cancer Immunotherapies Sales Breakdown by Type
6.2.1 North America Cancer Immunotherapies Sales Breakdown by Type (2016-2021)
6.2.2 North America Cancer Immunotherapies Sales Breakdown by Type (2022-2027)
6.3 North America Cancer Immunotherapies Sales Breakdown by Application
6.3.1 North America Cancer Immunotherapies Sales Breakdown by Application (2016-2021)
6.3.2 North America Cancer Immunotherapies Sales Breakdown by Application (2022-2027)
7 Europe Cancer Immunotherapies Market Facts & Figures
7.1 Europe Cancer Immunotherapies Sales by Company
7.1.1 Europe Cancer Immunotherapies Sales by Company (2016-2021)
7.1.2 Europe Cancer Immunotherapies Revenue by Company (2016-2021)
7.2 Europe Cancer Immunotherapies Sales Breakdown by Type
7.2.1 Europe Cancer Immunotherapies Sales Breakdown by Type (2016-2021)
7.2.2 Europe Cancer Immunotherapies Sales Breakdown by Type (2022-2027)
7.3 Europe Cancer Immunotherapies Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Cancer Immunotherapies Market Facts & Figures
8.1 China Cancer Immunotherapies Sales by Company
8.1.1 China Cancer Immunotherapies Sales by Company (2016-2021)
8.1.2 China Cancer Immunotherapies Revenue by Company (2016-2021)
8.2 China Cancer Immunotherapies Sales Breakdown by Type
8.2.1 China Cancer Immunotherapies Sales Breakdown by Type (2016-2021)
8.2.2 China Cancer Immunotherapies Sales Breakdown by Type (2022-2027)
8.3 China Cancer Immunotherapies Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Cancer Immunotherapies Market Facts & Figures
9.1 Japan Cancer Immunotherapies Sales by Company
9.1.1 Japan Cancer Immunotherapies Sales by Company (2016-2021)
9.1.2 Japan Cancer Immunotherapies Revenue by Company (2016-2021)
9.2 Japan Cancer Immunotherapies Sales Breakdown by Type
9.2.1 Japan Cancer Immunotherapies Sales Breakdown by Type (2016-2021)
9.2.2 Japan Cancer Immunotherapies Sales Breakdown by Type (2022-2027)
9.3 Japan Cancer Immunotherapies Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Cancer Immunotherapies Market Facts & Figures
10.1 Southeast Asia Cancer Immunotherapies Sales by Company
10.1.1 Southeast Asia Cancer Immunotherapies Sales by Company (2016-2021)
10.1.2 Southeast Asia Cancer Immunotherapies Revenue by Company (2016-2021)
10.2 Southeast Asia Cancer Immunotherapies Sales Breakdown by Type
10.2.1 Southeast Asia Cancer Immunotherapies Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Cancer Immunotherapies Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Cancer Immunotherapies Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Cancer Immunotherapies Market Facts & Figures
11.1 India Cancer Immunotherapies Sales by Company
11.1.1 India Cancer Immunotherapies Sales by Company (2016-2021)
11.1.2 India Cancer Immunotherapies Revenue by Company (2016-2021)
11.2 India Cancer Immunotherapies Sales Breakdown by Type
11.2.1 India Cancer Immunotherapies Sales Breakdown by Type (2016-2021)
11.2.2 India Cancer Immunotherapies Sales Breakdown by Type (2022-2027)
11.3 India Cancer Immunotherapies Sales Breakdown by Application
11.3.1 India Cancer Immunotherapies Sales Breakdown by Application (2016-2021)
11.3.2 India Cancer Immunotherapies Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Cancer Immunotherapies Business
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen Cancer Immunotherapies Products Offered
12.1.5 Amgen Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Cancer Immunotherapies Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Business Overview
12.3.3 Roche Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche Cancer Immunotherapies Products Offered
12.3.5 Roche Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Business Overview
12.4.3 Bristol-Myers Squibb Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Cancer Immunotherapies Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Cancer Immunotherapies Products Offered
12.5.5 Bayer Recent Development
12.6 Merck
12.6.1 Merck Corporation Information
12.6.2 Merck Business Overview
12.6.3 Merck Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Merck Cancer Immunotherapies Products Offered
12.6.5 Merck Recent Development
12.7 ARMO BioSciences (Eli Lilly)
12.7.1 ARMO BioSciences (Eli Lilly) Corporation Information
12.7.2 ARMO BioSciences (Eli Lilly) Business Overview
12.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Products Offered
12.7.5 ARMO BioSciences (Eli Lilly) Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Business Overview
12.8.3 Novartis Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis Cancer Immunotherapies Products Offered
12.8.5 Novartis Recent Development
12.9 Pfizer
12.9.1 Pfizer Corporation Information
12.9.2 Pfizer Business Overview
12.9.3 Pfizer Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pfizer Cancer Immunotherapies Products Offered
12.9.5 Pfizer Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Corporation Information
12.10.2 Johnson & Johnson Business Overview
12.10.3 Johnson & Johnson Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Johnson & Johnson Cancer Immunotherapies Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 AbbVie
12.11.1 AbbVie Corporation Information
12.11.2 AbbVie Business Overview
12.11.3 AbbVie Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AbbVie Cancer Immunotherapies Products Offered
12.11.5 AbbVie Recent Development
12.12 Gilead Sciences
12.12.1 Gilead Sciences Corporation Information
12.12.2 Gilead Sciences Business Overview
12.12.3 Gilead Sciences Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Gilead Sciences Cancer Immunotherapies Products Offered
12.12.5 Gilead Sciences Recent Development
13 Cancer Immunotherapies Manufacturing Cost Analysis
13.1 Cancer Immunotherapies Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cancer Immunotherapies
13.4 Cancer Immunotherapies Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cancer Immunotherapies Distributors List
14.3 Cancer Immunotherapies Customers
15 Market Dynamics
15.1 Cancer Immunotherapies Market Trends
15.2 Cancer Immunotherapies Drivers
15.3 Cancer Immunotherapies Market Challenges
15.4 Cancer Immunotherapies Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer